Literature DB >> 30204004

Ultrasound-guided laser ablation for local control of neck recurrences of medullary thyroid cancer. A feasibility study.

Agnese Persichetti1, Giancarlo Bizzarri2, Rinaldo Guglielmi3, Agnese Barnabei4, Antonio Bianchini2, Carmela Coccaro3, Marialuisa Appetecchia4, Enrico Papini3.   

Abstract

BACKGROUND: Surgery is the standard treatment for cervical metastases of medullary thyroid cancer (MTC) diagnosed after initial surgical treatment. Repeated neck dissections, however, carry an elevated risk of complications, have an adverse impact on the quality of life, and sometimes do not achieve cure of the disease Clinical case: In a patient who had undergone two cervical neck dissections complicated by accessory nerve injury, an US-guided laser ablation (LA) of a lymph node metastasis of MTC was performed. LA was performed with two treatments during a five month period. The procedure was carried out with one optical fiber and an energy delivery of 3300 and 360 Joules. Treatments were well tolerated and resulted in complete structural and biochemical cure during a 12 month follow-up. No major complication was registered.
CONCLUSIONS: LA is a promising tool for the management of relapsing cervical metastases that are localized in non- critical areas and are characterized by low progression rate. Advantages of LA are the outpatient setting, the absence of general anesthesia, the tolerability and the safety of the procedure. Thus, LA may be considered as an alternative approach to surgery or active surveillance for the management of local recurrences of MTC in selected patients.

Entities:  

Keywords:  Medullary thyroid carcinoma; cervical metastases; laser ablation; minimally invasive procedures

Mesh:

Year:  2018        PMID: 30204004     DOI: 10.1080/02656736.2018.1508759

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  6 in total

1.  European Thyroid Association and Cardiovascular and Interventional Radiological Society of Europe 2021 Clinical Practice Guideline for the Use of Minimally Invasive Treatments in Malignant Thyroid Lesions.

Authors:  Giovanni Mauri; Laszlo Hegedüs; Steven Bandula; Roberto Luigi Cazzato; Agnieszka Czarniecka; Oliver Dudeck; Laura Fugazzola; Romana Netea-Maier; Gilles Russ; Göran Wallin; Enrico Papini
Journal:  Eur Thyroid J       Date:  2021-05-25

2.  European Thyroid Association Survey on Use of Minimally Invasive Techniques for Thyroid Nodules.

Authors:  Laszlo Hegedüs; Andrea Frasoldati; Roberto Negro; Enrico Papini
Journal:  Eur Thyroid J       Date:  2020-03-27

3.  US-Guided Radiofrequency Ablation for Low-Risk Papillary Thyroid Microcarcinoma: Efficacy and Safety in a Large Population.

Authors:  Hyun Kyung Lim; Se Jin Cho; Jung Hwan Baek; Kang Dae Lee; Chang Woo Son; Jung Min Son; Seon Mi Baek
Journal:  Korean J Radiol       Date:  2019-12       Impact factor: 3.500

4.  Efficacy of radiofrequency ablation for metastatic papillary thyroid cancer with and without initial biochemical complete status.

Authors:  Wen-Chieh Chen; Chen-Kai Chou; Yen-Hsiang Chang; Pi-Ling Chiang; Lay-San Lim; Shun-Yu Chi; Sheng-Dean Luo; Wei-Che Lin
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-03       Impact factor: 6.055

5.  Ultrasound-Guided Percutaneous Laser Ablation of the Thyroid Gland in a Swine Model: Comparison of Ablation Parameters and Ablation Zone Dimensions.

Authors:  Fourat Ridouani; R Michael Tuttle; Mario Ghosn; Duan Li; Richard J Wong; James A Fagin; Sebastien Monette; Stephen B Solomon; Juan C Camacho
Journal:  Cardiovasc Intervent Radiol       Date:  2021-07-12       Impact factor: 2.797

6.  Long-Term Follow-Up of Single-Fiber Multiple Low-Intensity Energy Laser Ablation Technique of Benign Thyroid Nodules.

Authors:  Mattia Squarcia; Mireia Mora; Gloria Aranda; Enrique Carrero; Daniel Martínez; Ramona Jerez; Ricard Valero; Joan Berenguer; Irene Halperin; Felicia A Hanzu
Journal:  Front Oncol       Date:  2021-12-07       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.